Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
59 hedge funds and large institutions have $167M invested in Immune Design Corp. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 7 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 62 → 59 (-3)
39% less capital invested
Capital invested by funds: $275M → $167M (-$108M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
68% less call options, than puts
Call options by funds: $24K | Put options by funds: $74K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$4.41M |
| 2 |
TA
Teachers Advisors
New York
|
+$1.7M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.25M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$967K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$851K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.79M |
| 2 |
IHM
Iguana Healthcare Management
New York
|
-$1.41M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.14M |
| 4 |
Goldman Sachs
New York
|
-$409K |
| 5 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$396K |
IMDZ Hedge Fund Activity: Q3 2015 in Review
59 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q3 2015, worth a combined $167M — down 39% from $275M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of IMDZ and 4 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 25 added.
The largest buyer was RS Investment Management, adding an estimated $4.41M. The largest seller was BlackRock Advisors, cutting an estimated $1.79M.
- 59 institutional investors held Immune Design Corp. (IMDZ) as of Q3 2015, down from 62 in Q2 2015.
- Funds reported $167M of Immune Design Corp. stock for Q3 2015, down 39% quarter-over-quarter.
- 4 funds opened new Immune Design Corp. positions in Q3 2015 and 7 closed out, a net change of -3 holders.
- The largest Immune Design Corp. buyer in Q3 2015 was RS Investment Management, an estimated $4.41M added.
- The largest Immune Design Corp. seller in Q3 2015 was BlackRock Advisors, an estimated $1.79M sold.
Based on aggregated 13F filings for Q3 2015.